Diwata Macalino

CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

D. V. Von Hoff, Adam Siddiqui-Jain, J. Bliesath, 2012, Molecular Cancer Therapeutics.

7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.

Adam Siddiqui-Jain, Diwata Macalino, Nicole Streiner, 2011, Bioorganic & medicinal chemistry letters.

Preclinical Development CK 2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Ef fi cacy : Mechanistic Rationale for Drug Combination Therapy

D. V. Hoff, Adam Siddiqui-Jain, J. Bliesath, 2012 .

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells.

Adam Siddiqui-Jain, Diwata Macalino, Nicole Streiner, 2012, Bioorganic & medicinal chemistry letters.

Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

Adam Siddiqui-Jain, J. Bliesath, Diwata Macalino, 2012, ACS medicinal chemistry letters.

Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs.

Adam Siddiqui-Jain, Diwata Macalino, S. O'Brien, 2012, Bioorganic & medicinal chemistry letters.

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells.

Adam Siddiqui-Jain, Diwata Macalino, Nicole Streiner, 2012, Bioorganic & medicinal chemistry letters.